Cure My Disease

Don't miss your cure!

 Log in / Sign up

New cancer drug enters human testing for Tough-to-Treat tumors

NCT ID NCT06480552

Recruiting now Disease control Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. Source: ClinicalTrials.gov ↗

Summary

This early-stage trial is testing a new drug called TEV-56278, both alone and combined with an existing immunotherapy (pembrolizumab), for people with advanced solid tumors that have stopped responding to standard treatments. The study aims to find safe doses and see if the drug shows early signs of fighting cancer. About 240 participants will receive treatment for up to one year, with follow-up monitoring afterward.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Teva Investigational Site 11282

    RECRUITING

    Toronto, Ontario, M5G 2M9, Canada

  • Teva Investigational Site 12014

    RECRUITING

    Huntersville, North Carolina, 28078, United States

  • Teva Investigational Site 12015

    RECRUITING

    Detroit, Michigan, 48201, United States

  • Teva Investigational Site 12016

    RECRUITING

    Chicago, Illinois, 60611, United States

  • Teva Investigational Site 12017

    RECRUITING

    Los Angeles, California, 90025, United States

  • Teva Investigational Site 12018

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Teva Investigational Site 12019

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Teva Investigational Site 12021

    COMPLETED

    Lake Mary, Florida, 32746, United States

  • Teva Investigational Site 12023

    RECRUITING

    Cincinnati, Ohio, 45219, United States

  • Teva Investigational Site 12025

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • Teva Investigational Site 12058

    RECRUITING

    Pittsburgh, Pennsylvania, 15232, United States

Conditions

Explore the condition pages connected to this study.

ADVANCED SOLID TUMORS